Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial

[1]  P. Viale.  Candida Colonization and Candiduria in Critically Ill Patients in the Intensive Care Unit , 2012, Drugs.

[2]  M. Montagna,et al.  Candida Colonization Index in Patients Admitted to an ICU , 2011, International journal of molecular sciences.

[3]  M. Netea,et al.  Pathogenesis of invasive candidiasis , 2010, Current opinion in critical care.

[4]  M. Arendrup.  Epidemiology of invasive candidiasis , 2010, Current opinion in critical care.

[5]  D. Denning,et al.  Excess mortality, length of stay and cost attributable to candidaemia. , 2009, The Journal of infection.

[6]  J. Marchena-Gómez,et al.  Candida Isolation in Patients Hospitalized on a Surgical Ward: Significance and Mortality-Related Factors , 2009, World Journal of Surgery.

[7]  P. Carver,et al.  Evolving role of early antifungals in the adult intensive care unit , 2009, Critical care medicine.

[8]  M. Falagas,et al.  Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  J. Sobel,et al.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  A. Kumar.  Empirical Fluconazole versus Placebo for Intensive Care Unit Patients: A Randomized Trial , 2009 .

[11]  J. Nolla,et al.  Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[12]  B. Alexander,et al.  Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[13]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[14]  R. Grillot,et al.  Candidaemia in Europe: epidemiology and resistance. , 2006, International journal of antimicrobial agents.

[15]  J. Garnacho-Montero,et al.  A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization* , 2006, Critical care medicine.

[16]  M. Bassetti,et al.  Epidemiological trends in nosocomial candidemia in intensive care , 2006, BMC infectious diseases.

[17]  P. Preux,et al.  Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients , 2005, Intensive Care Medicine.

[18]  M. Wolff,et al.  Oral nystatin as antifungal prophylaxis in critically ill patients: an old SDD tool to be renewed? , 2005, Intensive Care Medicine.

[19]  Victoria J. Fraser,et al.  Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality , 2005, Antimicrobial Agents and Chemotherapy.

[20]  M. Milanese,et al.  Impact of selective decontamination of the digestive tract on fungal carriage and infection: systematic review of randomized controlled trials , 2005, Intensive Care Medicine.

[21]  L. Ostrosky-Zeichner.  Prophylaxis and treatment of invasive candidiasis in the intensive care setting , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[22]  A. Tortorano,et al.  Candidosis in the intensive care unit: a 20-year survey. , 2004, The Journal of hospital infection.

[23]  O. Faure,et al.  Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[24]  P. Olaechea,et al.  Economic Impact of Candida Colonization and Candida Infection in the Critically Ill Patient , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[25]  B. Guidet,et al.  Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. , 2002, Journal of critical care.

[26]  P. Kale-Pradhan,et al.  Therapeutic Dilemma of Fluconazole Prophylaxis in Intensive Care , 2002, The Annals of pharmacotherapy.

[27]  E. Anaissie,et al.  Revisiting the source of candidemia: skin or gut? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  R. Weinstein,et al.  Prophylactic antifungal therapy in the intensive care unit. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  P. Lipsett,et al.  Double-Blind Placebo-Controlled Trial of Fluconazole to Prevent Candidal Infections in Critically Ill Surgical Patients , 2001, Annals of surgery.

[30]  J. Sobel,et al.  Reply to Dr. Chandrasekar (Clin Infect Dis 2001; 32:320-1) and Drs. Marr and Boeckh (Clin Infect Dis 2001; 32:321). , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  R. Auckenthaler,et al.  Candida Colonization and Subsequent Infections in Critically III Surgical Patients , 1994, Annals of surgery.

[32]  B. Doebbeling,et al.  Investigation of the sequence of colonization and candidemia in nonneutropenic patients , 1994, Journal of clinical microbiology.

[33]  B. Zawacki,et al.  Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  R F Woolson,et al.  Hospital-acquired candidemia. The attributable mortality and excess length of stay. , 1988, Archives of internal medicine.

[35]  R. L. Simmons,et al.  The role of Candida in intraperitoneal infections. , 1980, Surgery.